These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30783852)

  • 1. ASO Author Reflections: Role of Genomic Assay to Predict Neoadjuvant Chemotherapy Response in Breast Cancer.
    Pease AM; James TA
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):573-574. PubMed ID: 30783852
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Disparities in Outcome and Surgical Management Following Neoadjuvant Chemotherapy for Breast Cancer.
    Relation T; Oppong BA
    Ann Surg Oncol; 2021 Oct; 28(11):6498-6499. PubMed ID: 33660126
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Ultrasound-Guided Restaging and Localization of Axillary Lymph Nodes After Neoadjuvant Chemotherapy.
    Kim WH; Kim HJ
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):644-645. PubMed ID: 30315382
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Using Tumor Genomics to Predict Axillary Response to Chemotherapy in Breast Cancer.
    James TA; Fan B
    Ann Surg Oncol; 2021 Mar; 28(3):1326-1327. PubMed ID: 33417122
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Moving Forward De-escalation of Axillary Surgery After Neoadjuvant Treatment in Breast Cancer.
    Rubio IT
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):638-639. PubMed ID: 30284130
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Bilateral Mastectomy After Neoadjuvant Therapy: An Ever-Increasing Trend?
    Kantor O; Yao K
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):650-651. PubMed ID: 30327968
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: How Can We Eliminate Breast Surgery in Patients Who Achieved Clinical Complete Response After Neoadjuvant Chemotherapy?
    Sawaki M; Kataoka A
    Ann Surg Oncol; 2023 Jun; 30(6):3233-3234. PubMed ID: 36765007
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Improving Patient Selection for Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy.
    Kantor O; James TA
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):640-641. PubMed ID: 30302645
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Reducing Axillary Lymph Node Dissections in Node-Positive Breast Cancer Patients.
    van der Noordaa MEM; Vrancken Peeters MTFD
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):677-678. PubMed ID: 30474766
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Limiting Axillary Surgery for Microinvasive Breast Cancer.
    James TA; Fan B
    Ann Surg Oncol; 2020 Oct; 27(11):4474. PubMed ID: 32488515
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Axillary Surgery for Breast Cancer: From Back to the Future, and Beyond.
    Lee J; Park HY
    Ann Surg Oncol; 2023 Aug; 30(8):4678-4679. PubMed ID: 36988751
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Entering the Era of Biomarker-Driven Management of the Axilla.
    DiNome ML; Marzese DM
    Ann Surg Oncol; 2022 Aug; 29(8):4725-4726. PubMed ID: 35415817
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: Molecular Signatures May Render Surgical Staging of the Axilla Obsolete.
    Orozco JIJ; Le J; Baker JL; Marzese DM; DiNome ML
    Ann Surg Oncol; 2022 Oct; 29(10):6415-6416. PubMed ID: 35918577
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: The Evolution of Axillary Management in Breast Cancer.
    Schwartz T; Marumoto AD; Giuliano AE
    Ann Surg Oncol; 2023 Feb; 30(2):1014-1015. PubMed ID: 36245054
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Elimination of Breast Cancer Surgery in Complete Responders After Neoadjuvant Chemotherapy: Imaging Perspective.
    Rauch GM
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):628-629. PubMed ID: 30244417
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: Use of Axillary Staging Surgery Before Systemic Therapy in Breast Cancer Highlights a Need for Implementation Science in Surgery.
    Iles K; Downs-Canner S
    Ann Surg Oncol; 2022 Dec; 29(Suppl 3):575-576. PubMed ID: 34599433
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: Role of Contrast-Enhanced Spectral Mammography in the Assessment of Residual Breast Cancer After Neoadjuvant Systemic Therapy.
    Hilal T; Patel BK
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):652-653. PubMed ID: 30324476
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: The Role of Imaging Modalities in Omitting Surgery in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Palshof FK; Kroman N; Tvedskov TF
    Ann Surg Oncol; 2021 Nov; 28(12):7430-7431. PubMed ID: 34023947
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: Neoadjuvant Chemotherapy Does Not Affect Short-Term Outcomes After Breast Cancer Surgery.
    Konishi T; Fujiogi M; Tanabe M; Seto Y; Yasunaga H
    Ann Surg Oncol; 2022 May; 29(5):3011-3012. PubMed ID: 34997419
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: Postmastectomy Radiotherapy for Breast Cancer Patients After Neoadjuvant Chemotherapy, by Molecular Subtype.
    Ma JC; Zhong XR; Luo T; Liu L
    Ann Surg Oncol; 2021 Sep; 28(9):5096-5097. PubMed ID: 33604825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.